Tenpoint Therapeutics

London, United Kingdom · Founded 2019 · Privately Held (backing)

Operator of a biotechnology platform intended to restore vision for people with degenerative ocular diseases. Tenpoint Therapeutics is based in London, United Kingdom and was founded in 2019. Its last reported valuation was $76.6 million in Jul 2023. It has raised $312 million.

Last reported valuation

$76.6M

Oct 2026

Priced at

—

Total raised

$312.1M

Last round

—

How much has Tenpoint Therapeutics raised?

$312.1Macross 0 recorded rounds

Free account

More of Tenpoint Therapeutics with a free account

·The complete investor list: 15 names
·Watch Tenpoint Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Tenpoint Therapeutics investors

15 investors are on record for Tenpoint Therapeutics, including F-Prime Capital, Qiming Venture Partners USA, Eight Roads and British Business Bank. By type, the record holds 4 venture capital firms and 1 family office.

For fundraisers

Raising for a company like Tenpoint Therapeutics?

15 investors have backed Tenpoint Therapeutics.

See all 15 investors →

Frequently asked about Tenpoint Therapeutics

How much has Tenpoint Therapeutics raised?: Tenpoint Therapeutics has raised $312.1M in total across 0 recorded funding rounds.